TIFAB forms a complex with TRAF6, reducing its stability by a lysosome-dependent mechanism, and mice transplanted with Tifab−/− HSPCs display a bone marrow failure like disease with cytopenias and myeloid differentiation skewing. Here, TIFAB is linked to Bone marrow hypocellularity.